Clinical Trial Update: Pedometer Activity Monitoring After ASCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pedometer-based activity monitoring after autologous stem cell transplantation in lymphoma and myeloma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Lymphoma, Myeloma | Phase 2 | Status: COMPLETED